{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-105548","form_type":"8-K","ticker":"TELA","cik":"0001561921","company_name":"TELA Bio, Inc.","filed_at":"2025-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.744946+00:00","generated_at":"2026-05-17T00:52:20.900005+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"TELA Bio appoints William Plovanic to board; expands board to seven members","bullets":["Board increased from six to seven members; Plovanic appointed as Class I director through 2026 annual meeting.","Plovanic is Managing Director, Healthcare Equity Research at Canaccord Genuity; also former CEO/CFO of Obalon Therapeutics.","Received initial equity grant: option for 17,550 shares (36-month vest) and RSU for 11,925 shares (3-year vest).","Annual board retainer of $45,000; will receive annual equity awards starting at 2026 meeting (11,700 options + 7,950 RSUs).","Plovanic is independent under Nasdaq rules; no related party transactions disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-105548","json":"https://secwatch.observer/filing/0001104659-25-105548.json","markdown":"https://secwatch.observer/filing/0001104659-25-105548.md","text":"https://secwatch.observer/filing/0001104659-25-105548.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1561921/000110465925105548/0001104659-25-105548-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1561921/000110465925105548/tm2530000d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:52:20.900005+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}